Tapewire

Nasdaq · USD

VCEL

Vericel Corp

Export transactions ↓
Tapewire entity
4481
SEC CIK
0000887359
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 34 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202601
Feb 202601
Mar 202604
Apr 202601
May 202607
Jun 202609
Jul 202603
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 17, 2024 Filed Oct 18, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:05 UTC
Hagen HeidiDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $3.74 $0.00
Disclosure

SEC source: 0001140361-24-043798 · form4.xml · derivative · entry 4

Hagen Heidi · CIK 0001585084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.

F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:05 UTC
Hagen HeidiDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $3.74 $0.00
Disclosure

SEC source: 0001140361-24-043798 · form4.xml · derivative · entry 3

Hagen Heidi · CIK 0001585084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.

F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:05 UTC
Hagen HeidiDirector
Exercise / conversionCommon Stock 6,000 $3.74 $22,440.00
Disclosure

SEC source: 0001140361-24-043798 · form4.xml · nonDerivative · entry 2

Hagen Heidi · CIK 0001585084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time.

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:05 UTC
Hagen HeidiDirector
Exercise / conversionCommon Stock 4,000 $3.74 $14,960.00
Disclosure

SEC source: 0001140361-24-043798 · form4.xml · nonDerivative · entry 1

Hagen Heidi · CIK 0001585084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-043696 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $41.38 $724,150.00
Disclosure

SEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,833 $0.00 Strike: $13.05 $0.00
Disclosure

SEC source: 0001140361-24-043695 · form4.xml · derivative · entry 3

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,833 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC SaleCommon Stock 5,833 $41.36 $241,252.88
Disclosure

SEC source: 0001140361-24-043695 · form4.xml · nonDerivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.

Read SEC document
October 16, 2024 Filed Oct 18, 2024 20:05 UTC Exercise / conversionCommon Stock 5,833 $13.05 $76,120.65
Disclosure

SEC source: 0001140361-24-043695 · form4.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2024 Filed Oct 4, 2024 20:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,833 $0.00 Strike: $13.05 $0.00
Disclosure

SEC source: 0001140361-24-042882 · form4.xml · derivative · entry 3

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,833

Underlying: Common Stock · 5,833 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.

Read SEC document
October 02, 2024 Filed Oct 4, 2024 20:06 UTC SaleCommon Stock 5,833 $40.35 $235,361.55
Disclosure

SEC source: 0001140361-24-042882 · form4.xml · nonDerivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.

Read SEC document
October 02, 2024 Filed Oct 4, 2024 20:06 UTC Exercise / conversionCommon Stock 5,833 $13.05 $76,120.65
Disclosure

SEC source: 0001140361-24-042882 · form4.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:06 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 568 $41.90 $23,799.20
Disclosure

SEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 3

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,124

F4 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:06 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 937 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-042559 · form4.xml · derivative · entry 4

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 938

Underlying: Common Stock · 937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F7 · price: The Fair Market Value of the vested derivative securities is $42.25 per share.

F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025.

F6 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:06 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Tax withholdingCommon Stock 369 $42.25 $15,590.25
Disclosure

SEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 2

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,692

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:06 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionCommon Stock 937 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 1

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 30, 2024 Filed Feb 13, 2025 21:05 UTC
Halpin MichaelChief Operating Officer
GrantCommon Stock 120 $35.91 $4,309.20
Disclosure

SEC source: 0001140361-25-004301 · form5.xml · nonDerivative · entry 2

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,499

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 30, 2024 Filed Feb 13, 2025 21:05 UTC
Flynn Sean C.Chief Legal Officer
GrantCommon Stock 49 $35.91 $1,759.59
Disclosure

SEC source: 0001140361-25-004300 · form5.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 756

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 30, 2024 Filed Feb 13, 2025 21:05 UTC
Mara Joseph Anthony JrChief Financial Officer
GrantCommon Stock 76 $35.91 $2,729.16
Disclosure

SEC source: 0001140361-25-004299 · form5.xml · nonDerivative · entry 1

Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,511

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 18, 2024 Filed Sep 20, 2024 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,834 $0.00 Strike: $13.05 $0.00
Disclosure

SEC source: 0001140361-24-041562 · form4.xml · derivative · entry 3

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,666

Underlying: Common Stock · 5,834 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 20:05 UTC SaleCommon Stock 5,834 $45.54 $265,680.36
Disclosure

SEC source: 0001140361-24-041562 · form4.xml · nonDerivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 20:05 UTC Exercise / conversionCommon Stock 5,834 $13.05 $76,133.70
Disclosure

SEC source: 0001140361-24-041562 · form4.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 12, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · derivative · entry 6

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
September 12, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $43.90 $768,250.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 4

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 12, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $43.37 $758,975.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 04, 2024 Filed Sep 5, 2024 20:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.74 $0.00
Disclosure

SEC source: 0001140361-24-040228 · form4.xml · derivative · entry 3

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.

F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Read SEC document
September 04, 2024 Filed Sep 5, 2024 20:06 UTC SaleCommon Stock 5,000 $48.58 $242,900.00
Disclosure

SEC source: 0001140361-24-040228 · form4.xml · nonDerivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.

Read SEC document
September 04, 2024 Filed Sep 5, 2024 20:06 UTC Exercise / conversionCommon Stock 5,000 $3.74 $18,700.00
Disclosure

SEC source: 0001140361-24-040228 · form4.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $10.95 $0.00
Disclosure

SEC source: 0001140361-24-040225 · form4.xml · derivative · entry 3

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,604

Underlying: Common Stock · 10,000 shares

Expires 2028-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
SaleCommon Stock 10,000 $49.83 $498,300.00
Disclosure

SEC source: 0001140361-24-040225 · form4.xml · nonDerivative · entry 2

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,229

F2 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
September 03, 2024 Filed Sep 5, 2024 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionCommon Stock 10,000 $10.95 $109,500.00
Disclosure

SEC source: 0001140361-24-040225 · form4.xml · nonDerivative · entry 1

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · derivative · entry 6

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $46.24 $809,200.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 4

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $45.17 $790,475.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC GrantStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $3.74 $0.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · derivative · entry 6

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

F4 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.

F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.74 $0.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · derivative · entry 5

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F2 · derivative.exercise_date: These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.

F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC SaleCommon Stock 2,000 $45.99 $91,980.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 4

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,900

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC Exercise / conversionCommon Stock 2,000 $3.74 $7,480.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 3

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC SaleCommon Stock 5,000 $45.92 $229,600.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 2

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,900

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:05 UTC Exercise / conversionCommon Stock 5,000 $3.74 $18,700.00
Disclosure

SEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 1

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 18, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · derivative · entry 6

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
July 18, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $51.40 $899,500.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 4

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.